Veronica Lubkov

Business Development Associate at Milestone Pharmaceuticals - Montreal, QC, US

Veronica Lubkov's Contact Details
HQ
514-336-0444
Location
Durham, North Carolina, United States
Company
Milestone Pharmaceuticals
Veronica Lubkov's Company Details
Milestone Pharmaceuticals logo, Milestone Pharmaceuticals contact details

Milestone Pharmaceuticals

Montreal, QC, US • 50 - 99 Employees
BioTech/Drugs

Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing the investigational new drug etripamil for the treatment of cardiovascular indications. Etripamil is a novel, potent and short-acting calcium channel blocker designed by Milestone and being developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of PSVT as they occur. Milestone is actively recruiting patients for a Phase 3 clinical trial of etripamil for the treatment of PSVT. Milestone plans to initiate a Phase 2 clinical trial in atrial fibrillation, another rapid heart rate condition, and expects to subsequently initiate an additional Phase 2 clinical trial in angina to establish proof-of-concept for the broader use of etripamil.

B2B Biotechnology Cleantech Healthcare Pharmaceuticals Wind Power Biotech Biotech
Details about Milestone Pharmaceuticals
Frequently Asked Questions about Veronica Lubkov
Veronica Lubkov currently works for Milestone Pharmaceuticals.
Veronica Lubkov's role at Milestone Pharmaceuticals is Business Development Associate.
Veronica Lubkov's email address is ***@milestonepharma.com. To view Veronica Lubkov's full email address, please signup to ConnectPlex.
Veronica Lubkov works in the BioTech/Drugs industry.
Veronica Lubkov's colleagues at Milestone Pharmaceuticals are Joseph Oliveto, Ashley Sconzo, Harish Pimplaskar, Nicole DeVirgiliis, Lorenz Muller, Miguel Romero Sepúlveda, Natacha Saint-Lary and others.
Veronica Lubkov's phone number is 514-336-0444
See more information about Veronica Lubkov